Dave Hastings
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dave Hastings
Earlier roles on record: CFO at Arbutus Biopharma Corp (ABUS) until March 27, 2025. Arbutus Biopharma Corp reported in an 8-K filed April 3, 2025 that Dave Hastings was terminated as Chief Financial Officer, effective March 27, 2025. Dave Hastings has spoken on 6 earnings calls across 1 company, most recently for Arbutus Biopharma Corp on November 21, 2024.
“the Company terminated, without cause, David Hastings as Chief Financial Officer of the Company, effective as of the end of the day on March 27, 2025.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2025-03-27
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.